Celyad Oncology SA (CYAD) Stock Analyst Earnings Estimates
NASDAQ:CYAD - Nasdaq - US1512052002 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.115M -12.01% | 6K -99.81% | 5K -16.67% | -100.00% | N/A | |
| EBITDA YoY % growth | -36.874M -48.16% | -27.091M 26.53% | -15.145M 44.10% | -24.927M -64.21% | N/A 82.58% | |
| EBIT YoY % growth | -37.988M -42.80% | -28.879M 23.98% | -16.977M 41.21% | -26.842M -55.45% | N/A 78.12% | |
| Operating Margin | -1,219.52% | -481,316.67% | -339,540.00% | N/A | N/A | |
| EPS YoY % growth | N/A -0.91% | N/A 35.44% | N/A 8.28% | -1.31 38.42% | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |